Teruhisa Tanabe Selected Research

Teruhisa Tanabe Research Topics

Disease

7	Ventricular Tachycardia 04/2017 - 03/2003
6	Myocardial Infarction 04/2017 - 09/2006
6	Heart Arrest (Cardiac Arrest) 01/2013 - 03/2003
5	Heart Failure 03/2014 - 09/2002
4	Cardiac Arrhythmias (Arrythmia) 01/2018 - 01/2007
3	Atrial Fibrillation 01/2018 - 06/2009
2	Acute Coronary Syndrome 03/2019 - 12/2016
2	Ventricular Fibrillation 01/2013 - 04/2010
2	Shock 04/2010 - 03/2009
2	Bradycardia 06/2009 - 03/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2019
1	Heart Neoplasms 01/2018
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2018
1	Mediastinal Neoplasms 01/2018
1	Body Temperature Changes 09/2015
1	Brugada Syndrome 09/2015
1	Hypertension (High Blood Pressure) 03/2014
1	Syncope (Fainting) 01/2013
1	Thrombosis (Thrombus) 05/2011
1	AIDS-Related Complex (ARC) 05/2011
1	Neointima 08/2010
1	Coronary Stenosis (Coronary Artery Stenosis) 08/2010
1	Heart Diseases (Heart Disease) 03/2010
1	Sudden Death 06/2009
1	Heart Injuries 03/2009
1	Angina Pectoris 03/2009
1	Ischemia 03/2009
1	Respiratory Insufficiency (Respiratory Failure) 01/2009
1	Poisoning 01/2009
1	Starvation 08/2007
1	Infarction (Infarctions) 12/2006
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2006
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2005
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2005
1	Sleep Apnea Syndromes (Sleep Apnea) 08/2005
1	Central Sleep Apnea (Central Sleep Apnea Syndrome) 08/2005
1	Apnea 08/2005
1	Out-of-Hospital Cardiac Arrest 03/2003
1	Thrombocytopenia (Thrombopenia) 01/2003
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2002
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2002

Drug/Important Bio-Agent (IBA)

5	nifekalantIBA 04/2010 - 03/2003
4	Pharmaceutical PreparationsIBA 03/2014 - 09/2005
3	Connexin 43 (Connexin43)IBA 04/2017 - 12/2006
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2007 - 03/2003
1	Polyvinyl Chloride (PVC)IBA 01/2018
1	CarbonIBA 01/2018
1	ElectrolytesIBA 09/2015
1	Angiotensin Receptor AntagonistsIBA 03/2014
1	Losartan (Cozaar)FDA LinkGeneric 03/2014
1	DiureticsIBA 03/2014
1	Drug CombinationsIBA 03/2014
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 03/2014
1	N 30IBA 01/2013
1	Sirolimus (Rapamycin)FDA Link 08/2010
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2010
1	Amiodarone (Amiodarona)FDA LinkGeneric 04/2010
1	Bepridil (Vascor)FDA Link 06/2009
1	EnzymesIBA 03/2009
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2009
1	Nicotine FDA Link 08/2007
1	Annexin A5IBA 08/2007
1	erucylphosphocholineIBA 08/2007
1	PotassiumIBA 01/2007
1	lipoprotein cholesterolIBA 01/2006
1	Glucose (Dextrose)FDA LinkGeneric 01/2006
1	Triglycerides (Triacylglycerol)IBA 01/2006
1	Fibrinogen (Factor I)FDA Link 01/2006
1	CholesterolIBA 01/2006
1	oxidized low density lipoproteinIBA 09/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2005
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2005
1	Oxygen (Dioxygen)IBA 08/2005
1	Epinephrine (Adrenaline)FDA LinkGeneric 03/2003
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2003
1	Amrinone (Amrinon)FDA Link 01/2003

Therapy/Procedure

4	Therapeutics 03/2010 - 09/2002
3	Resuscitation 09/2015 - 03/2003
2	Percutaneous Coronary Intervention 03/2019 - 12/2016
2	Stents 05/2011 - 08/2010
2	Cardiopulmonary Resuscitation (CPR) 12/2009 - 09/2006
1	Heavy Ion Radiotherapy 01/2018
1	Drug-Eluting Stents 05/2011
1	Electric Countershock (Cardioversion) 04/2010
1	Microspheres (Microsphere) 12/2006
1	Anesthesia 09/2006
1	Blood Component Removal (Apheresis) 09/2005
1	Cardiac Resynchronization Therapy 09/2002